Pravastatin combined coronary heart disease Tongxinluo Capsule Clinical observation of patients with hypertension and pulse pressure_0.doc
- 1、本文档共8页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Pravastatin combined coronary heart disease Tongxinluo Capsule Clinical observation of patients with hypertension and pulse pressure_0
PAGE \* MERGEFORMAT 8
Pravastatin combined coronary heart disease Tongxinluo Capsule Clinical observation of patients with hypertension and pulse pressure
OF: He Zhiwei, Yu Peng description, Lu Bangfu
[Keywords:] pravastatin; Tongxinluo capsule; coronary heart disease; Hypertension; pulse pressure; C-reactive protein
August 2007 -2009 in June, the author of 63 cases of hospital out-patient Department of Cardiology, coronary heart disease in hypertensive patients as objects, observe the pravastatin control of the joint capsule Tongxinluo the role of pulse pressure, are reported below.
1 Materials and Methods
1.1 Case selection criteria
Choice is regular use of antihypertensive medication treatment of coronary heart disease patients with hypertension, taking drugs, including aspirin, nitrates, metoprolol, enalapril, amlodipine equality, use of antihypertensive medication for 6 months, blood pressure is stable, not taking any lipid lowering drugs and Chinese medicines for promoting blood circulation. coronary heart disease diagnosis in 1979 the International Society of Cardiology and the World Health Organization has developed diagnostic criteria of coronary heart disease, some patients confirmed by coronary angiography; The diagnosis of hypertension established in 1999 with reference to the diagnostic criteria of hypertension [1]. selected pulse pressuregt; = 60 mm Hg (1 mm Hg = 0.133 kPa), serum cholesterol 4.66 ~ 6.8 mmol / L. exclude secondary hypertension, acute coronary syndrome, arrhythmia, heart valve disease, peripheral vascular disease and other serious diseases systems.
1.2 General Information
63 patients were randomly divided into conventional treatment group, pravastatin group, pravastatin Tongxinluo joint capsule group (combined group), all 21 patients. The conventional group 10 males and 11 females, aged 53 to 77 years old, average (67.0 + -9.6 years), blood pressure (146/76 + -16 / 8) mm Hg, heart rate (72 + -9) times / min
您可能关注的文档
- Porridge on the therapy and nursing Xiaoeryanshi.doc
- Poria Poria in different regions Comparison of acid_0.doc
- Poria ultrafine volatile constituents.doc
- Poria Atractylodes Decoction regulation of vasoactive intestinal peptide in rat spleen total polysaccharides Technology.doc
- Porphyromonas gingivalis strains induced degranulation in vitro leukocyte.doc
- Portal 'real estate speculators'.doc
- Poria Root Liquid Song mycelium and the fermentation of polysaccharide.doc
- Porous biphasic calcium phosphate ceramics in posterior spinal fusion of bone formation and degradation characteristics of histological.doc
- Portal hypertension variceal hemorrhage treatment of.doc
- Portal pulmonary hypertension aged 15 cases.doc
文档评论(0)